However, if the use of insulin analogues and conventional insulin secretagogues, which lead to increased levels of circulating insulin [290], has been associated with increased risk of cancer [121,122,291,292], metformin and thiazolidinediones (TZDs) may have the potential to prevent tumor development. The gene discussed is INS; the disease is cancer.